A Phase II Study of Venetoclax in Combination With Dose-adjusted EPOCH-R or R-CHOP for Patients With Richter's Syndrome

NCT03054896 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Richter Syndrome

Interventions

DRUG: Venetoclax
OTHER: DA-EPOCH-R
OTHER: R-CHOP

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]